MA

Milind Anil Patil

Active Director Director DIN 02546815
DIN 02546815 First appointment Feb 2009 Primary industry Food and Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Feb 2009
Shareholding value •••• Premium profile

About Milind Anil Patil

Data last updated:

Milind Anil Patil is a Director at Parag Milk Foods Limited (since 2025) and Director at Rubicon Research Limited (since 2024). The companies operate in Food and Beverages, Chemicals and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹4,345 Cr; the largest is Parag Milk Foods Limited at ₹3,472 Cr (FY 2025). Earlier, Milind Anil Patil was a Cfo at Pfizer Limited (2018–2023) and Director at Novartis Comprehensive Leprosy Care Association (2014–2016) and 3 more.

DIN 02546815
Primary Designation Director
Industry Food and Beverages
First Appointment 14 Feb 2009
Oldest Company Age 33 yrs
Largest company Parag Milk Foods Limited · ₹3,472 Cr (FY 2025)
Combined revenue ₹4,345 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parag Milk Foods Limited L15204PN1992PLC070209
Director22 May 20251992₹3,472 Cr (FY 2025)Active
Rubicon Research Limited L73100MH1999PLC119744
Director11 Jul 20241999₹872 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pfizer Limited L24231MH1950PLC008311
Cfo16 Aug 20181950₹2,454 Cr (FY 2025)Active
Director29 Sep 20141994Under Liquidation
Additional Director16 Sep 20151997₹94.53 Cr (FY 2025)Active
Director18 Sep 20151999₹2,237 Cr (FY 2025)Active
Novartis Healthcare Private Limited U15202MH1997PTC111257
Alternate Director14 Feb 20091997₹6,088 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rubicon Research Limited
Parag Milk Foods Limited
Pfizer Limited
Novartis Comprehensive Leprosy Care Association
Premium access

Shareholding and investment profile for Milind Anil Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Milind Anil Patil

Milind Anil Patil currently holds 2 directorships: Parag Milk Foods Limited (Director, since 22 May 2025, revenue ₹3,472 Cr (FY 2025)); Rubicon Research Limited (Director, since 11 Jul 2024, revenue ₹872 Cr (FY 2024)).

Milind Anil Patil was first appointed on 14 Feb 2009 as Alternate Director at Novartis Healthcare Private Limited. The most recent appointment on record is 22 May 2025 at Parag Milk Foods Limited.

The 2 current companies of Milind Anil Patil that report revenue have a combined latest revenue of ₹4,345 Cr: Parag Milk Foods Limited ₹3,472 Cr (FY 2025); Rubicon Research Limited ₹872 Cr (FY 2024).

Milind Anil Patil held 5 earlier board appointments: Pfizer Limited (Cfo, 16 Aug 2018 to 30 Nov 2023); Novartis Comprehensive Leprosy Care Association (Director, 29 Sep 2014 to 28 Mar 2016); Chiron Behring Vaccines Private Limited (Additional Director, 16 Sep 2015 to 31 Mar 2016); Alcon Laboratories (India) Private Limited (Director, 18 Sep 2015 to 18 Nov 2016); Novartis Healthcare Private Limited (Alternate Director, 14 Feb 2009 to 07 Jul 2016).

The current boards of Milind Anil Patil's companies include Akshali Shah (Parag Milk Foods Limited), Amitabha Mukhopadhyay (Parag Milk Foods Limited), Devendra Prakash Shah (Parag Milk Foods Limited), Dnyanesh Vishnu Darshane (Parag Milk Foods Limited), Namrata Samsher Garud (Parag Milk Foods Limited), Nikhil Kishorchandra Vora (Parag Milk Foods Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available